TORONTO - Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.

One of the highest yields you can get right now is from Pfizer ( PFE 0.90%). The healthcare giant offers a yield of 6.8%, ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the vaccine technology continue to play out on several other fronts.

Both Pfizer Canada and Moderna Canada told The Canadian Press on Thursday that the U.S. backing away from mRNA vaccines should not affect availability of their updated COVID-19 vaccines in Canada ...

Pfizer CentreOne is one of the industry’s longest-running integrated CDMOs, and it enjoys the ability to tap into Pfizer’s vast manufacturing network, which spans 35 sites around the globe.

Amid thousands of evacuations and the spread of smoke to the United States, the Canadian armed forces and the Coast Guard were summoned to help battle the blazes.

Pfizer Earnings: Impressive Q2 Results Bolster 2025, but Awaiting More Pipeline Data Pfizer stock remains undervalued.

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart ...

Pfizer exceeds analyst expectations with $0.78 EPS and $14.7B revenue in Q2 2025, beating estimates by significant margins despite recent stock struggles.